Cooperative Agreement NU01DD000055
Award Date
9/30/24
Completion Date
9/29/29
Dollars Obligated
$1M
Funding Federal Agency
National Center on Birth Defects and Developmental Disabilities
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.184
Assistance Type
Cooperative Agreement
Place of Performance
New York, USA
Similar Awards
The federal Cooperative Agreement award titled "The North Carolina Congenital Heart Disease Surveillance Network" is funded by the National Center on Birth Defects and Developmental Disabilities, which is part of the Centers for Disease Control and Prevention (CDC). This $1,498,368 award, effective from September 30, 2024 to September 29, 2029, supports non-research activities aimed at reducing health disparities and improving the health of people with mobility limitations and/or...
This Cooperative Agreement award of $994,368 from the Centers for Disease Control and Prevention's (CDC) National Center on Birth Defects and Developmental Disabilities (CFDA 93.184 Disabilities Prevention) will support the University of Utah's surveillance of congenital heart defects among children, adolescents, and adults in the U.S. Virgin Islands. The award, effective from September 30, 2024 to September 29, 2029, will fund the university's efforts to develop, implement, evaluate, and...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Disabilities Prevention Federal Grant Program (CFDA 93.184) provides $1,100,000.00 in funding to Emory University to conduct surveillance of congenital heart defects among children, adolescents, and adults. The award period runs from September 30, 2024 through September 29, 2029. Emory University, a prominent private research university, will leverage its expertise in biomedical research,...
This Cooperative Agreement award for $650,398 from the National Center on Birth Defects and Developmental Disabilities, under the Disabilities Prevention program (CFDA 93.184), supports efforts to advance the surveillance of congenital heart defects (CHD) in Indiana. The key products and services being delivered include: Conducting population-based surveillance of infants, adolescents, and adults with CHD to identify predictors and outcomes, including for adults with CHD (ACHD). Developing and...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $1,000,000 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the Disabilities Prevention Grant Program (CFDA 93.184) to conduct surveillance of congenital heart defects among children, adolescents, and adults. The award has a performance period from September 30, 2024 to September 29, 2029. As part of this grant, UTHealth has issued a $304,430 sub-award to Baylor College of...
This $3,364,600.00 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) supports Health Research, Inc.'s delivery of public health research, data collection, and community-based program implementation services focused on chronic disease prevention and management. The award will fund a five-year project (September 30, 2024 to June 29, 2029) for Health Research, Inc. to conduct...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) provides $900,000.00 in funding to Health Research, Inc.'s Center for Environmental Health Division to conduct surveillance of muscular dystrophies. The project will run from September 1, 2024 through September 1, 2028. Health Research, Inc., a non-profit organization based in Menands, New York, will carry out this public health...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $286,510 Cooperative Agreement under the Blood Disorder Program: Prevention, Surveillance, and Research (CFDA 93.080) to the Center for Public Health Innovation, a woman-owned non-profit organization, for the Sickle Cell Data Collection Program - 2023. This 5-year project, beginning on September 30, 2023, aims to work with state health agencies and other partners to plan, develop, implement, coordinate, and evaluate programs and...
This $680,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) Disabilities Prevention program (CFDA 93.184) supports the New York State Department of Health (NYSDOH) in developing population-based surveillance of individuals of all ages with spina bifida living in 14 New York counties. The project aims to estimate prevalence, mortality, and survival for all age groups by linking data from the state birth defects registry, clinics, hospitals, Medicaid,...
This $161,500 Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant is intended to establish basic science-clinical collaborations to understand the molecular mechanisms of heterotaxy, a severe form of congenital heart disease that affects 3-4% of patients with congenital heart defects. The funding will support research at the University of Virginia to...